DirectorsTalk LSE Stock market news, financial, press release, articles and interviews 
Burford Capital (LON: BUR) has announced its interim results for 1H’19 and has produced another excellent set of figures. After stripping out third-party interests, revenue was up 40% to $287m ...
Read Article »Home » Hardman Research
Hardman Research
-
Gateley Plc Excellent full-year results
-
ARBUTHNOT BANKING GROUP 1H’19 results: diversified, low-risk growth continues
-
Koovs Plc New year started with a bang
-
City of London Investment Group Finishing ahead in a volatile year for markets
-
Redx Pharma Phase I trial resumed
-
Burford Capital Petersen appeals to investors
-
Arbuthnot Banking Group Plc Mortgage portfolio acquisitions
-
Oxford BioMedica Eying up long-term value
-
Allergy Therapeutics plc Successful legal outcome removes uncertainty
-
Volta Finance Manager’s Hardman & Co Forum presentation
-
Oxford BioMedica De-leveraging the balance sheet
-
Tissue Regenix Credit facilities expand cash runway to 2021
-
Non-Standard Finance Back to basics
-
IPSX The first regulated property exchange in the world
-
Anglo Asian Mining Prodigious cashflow AND bigger “system” potential
-
R.E.A. Holdings Strong production continues; deferred 1H pref. dividend
-
Palace Capital Conversion to REIT status; FY19 results announced
-
RM Secured Direct Lending Predictable revenue streams generating high yield
-
AstraZeneca Where has all the cash gone?
-
LightwaveRF 1H’19 results: 120% YoY revenue growth
-
Chamberlin Plc Trading remains difficult; forecasts lowered
-
Morses Club Plc Steady, reliable core, growth in new business lines
-
Urban Logistics Plenty of future growth stored up
-
Titon Holdings Plc You need hands
-
Allergy Therapeutics House dust mite vaccine – clinical progressDraft
-
Palace Capital Portfolio and trading update
-
Artificial Solutions 1Q’19 results – customer traction, numbers on track
-
Investment Companies: Understanding the deepest discounts
-
Advanced Oncotherapy Commercialising a breakthrough technology
-
Shield Therapeutics All in the execution
-
How small and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues
-
Neodecortech Strong 2018, robustly positioned for 2019
-
‘How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues’
-
Arbuthnot Banking Group 2018 results: growth and diversity
-
Diurnal Group Plc Clarity for Chronocort regulatory pathway
-
Warpaint London PLC FY’18 sales: remains profitable despite weak UK market
-
City of London Investment Group Market bounce gives FUM bounce
-
Advanced Oncotherapy Preparing for commercialisation
-
INTERVIEW: Primary Health Properties Dividends – Hardman & Co Analysis
-
Filta Group Strong and transformative year in 2018
